Analyze longitudinal PEth trends to interpret long-term alcohol consumption patterns following Roux-en-Y gastric bypass and sleeve gastrectomy. Evaluate sex-specific risk differences in postoperative alcohol use and integrate these findings into bariatric follow-up strategies. Assess the advantages and limitations of PEth testing compared with self-reported alcohol measures in bariatric populations. Apply evidence from long-term PEth monitoring to optimize postoperative surveillance and counseling protocols in bariatric practice.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
This is a journal-based activity. Credit is earned after completing the required reading and assessment; the amount shown is the provider-reported available credit.
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Specialties served/covered
- No reviews yet. Be the first to share yours.
- Journal-based
- Credit · Up to 1 credit
- MOC · Up to 1 point
- Fee · varies
-
ReleasedJun 1, 2026
-
Last day to claim creditJun 2, 2029 3 years left
-
American Society for Metabolic and Bariatric Surgery April 2026 (B): Cannabis use before and after metabolic and bariatric surgery and its association with alcohol use
-
American Society for Metabolic and Bariatric Surgery November 2025 (A): Prevalence of dysphagia after Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a national propensity score study
-
American Society for Metabolic and Bariatric Surgery August 2024 A: Hypovitaminosis D and hyperparathyroidism: a 5-year postoperative follow-up of 30,458 gastric bypass and sleeve gastrectomy patients
-
Obesity Medicine Association Obesity Medicine 2026 – GLP-1 Timing after Bariatric Surgery: A Case-Based Guide (Recorded)
-
American Society of Addiction Medicine Reductions in World Health Organization Risk Drinking Level are Associated with Reductions in Alcohol Use Disorder Diagnosis and Criteria Evidence from an Alcohol Pharmacotherapy Trial
-
Great Valley Publishing Company 2025 Recorded Symposium Session: Life After GLP-1 Agonist Therapy for Weight Loss
